If you experience any unexpected adverse reaction, please contact our
Pharmacovigilance department:
E-Mail: pharmacovigilance@curiumpharma.com
Tel.: +43 (0)664 3515021
If you experience any unexpected adverse reaction, please contact our
Pharmacovigilance department:
E-Mail: pharmacovigilance@curiumpharma.com
Tel.: +43 (0)664 3515021
For inquiries please contact us, we will be happy to assist you!
Curium acquired IASON in June of 2021, further expanding its footprint in Europe for its broad portfolio of life saving diagnostic solutions. Learn more on Curium’s website